Ludwigshafen, Germany

Volker Nimmrich

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 38(Granted Patents)


Location History:

  • Ludwigshafen, DE (2010 - 2015)
  • Heidelberg, DE (2012 - 2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Volker Nimmrich: A Pioneer in Antibody Research

Introduction

Volker Nimmrich, an accomplished inventor based in Ludwigshafen, Germany, has made significant contributions to the field of biotechnology. With a portfolio of seven patents, he is renowned for his innovative work focusing on therapeutic antibodies and their applications. His discoveries reflect his commitment to advancing medical science and improving treatment options for various diseases.

Latest Patents

Nimmrich's latest patents showcase his expertise in antibody engineering. One notable patent involves “Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof.” This invention entails isolated proteins, primarily monoclonal antibodies, which effectively bind to the RAGE protein. The unique ability of these antibodies to inhibit the binding of RAGE to its ligands opens avenues for treating diseases associated with pathophysiological ligands of RAGE, such as misfolded proteins like amyloid β and advanced glycation-end-products.

Another significant patent led by Nimmrich includes “Carboxamide compounds and their use as calpain inhibitors.” This invention centers around novel carboxamide compounds that serve as inhibitors of calpain, a calcium-dependent cysteine protease. The implications of these compounds are substantial, as they provide potential therapeutic avenues for disorders linked with elevated calpain activity.

Career Highlights

Throughout his career, Volker Nimmrich has worked with esteemed companies, including Abbott GmbH & Co. KG and AbbVie Deutschland GmbH & Co. KG. His professional journey is marked by dedicated research and development within the pharmaceutical sector, focusing on innovative therapeutic solutions.

Collaborations

In his quest for innovation, Nimmrich has collaborated with notable colleagues in the field, including Andreas Kling and Wilfried Hornberger. Their joint efforts have contributed to the advancement of scientific understanding and led to the successful development of valuable healthcare solutions.

Conclusion

Volker Nimmrich's contributions to the field of biotechnology through his patents reflect his deep commitment to innovation in medical research. His work on therapeutic antibodies and calpain inhibitors positions him as a key figure in the ongoing development of treatments for complex diseases, showcasing the impact of inventive minds in advancing healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…